United States · FDA National Drug Code directory
Mirtazapine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-0664_4a352bef-c4c5-4ce4-aca3-05d53469518b
- Product NDC
- 71335-0664
- Form
- TABLET, FILM COATED
- Composition / generic term
- Mirtazapine
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090817
- Source listing expiry
- 20261231
Source-listed ingredients
- MIRTAZAPINE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (71335-0664-1) · 71335-0664-1
- 60 TABLET, FILM COATED in 1 BOTTLE (71335-0664-2) · 71335-0664-2
- 90 TABLET, FILM COATED in 1 BOTTLE (71335-0664-3) · 71335-0664-3
- 120 TABLET, FILM COATED in 1 BOTTLE (71335-0664-4) · 71335-0664-4
- 15 TABLET, FILM COATED in 1 BOTTLE (71335-0664-5) · 71335-0664-5
- 180 TABLET, FILM COATED in 1 BOTTLE (71335-0664-6) · 71335-0664-6
- 45 TABLET, FILM COATED in 1 BOTTLE (71335-0664-7) · 71335-0664-7
- 21 TABLET, FILM COATED in 1 BOTTLE (71335-0664-8) · 71335-0664-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →